Colorectal Polyps: Classification, Risk Factors, Dietary Prevention, and the Diagnostic Role of Colonoscopy

The term 'colorectal polyp' designates any discrete macroscopic tissue mass projecting from the surrounding mucosal surface into the luminal cavity. Morphologically, polyps are classified as pedunculated (attached via an elongated stalk) or sessile (broad-based, flat against the colonic wall). Epidemiological data indicate that polyps are present in 25–30% of adults over 50 years of age, with higher prevalence among males. While most lesions remain initially benign, histopathological evaluation is obligatory, as silent progression along the adenoma-carcinoma sequence typically spans 7–12 years.

Histopathologically, colorectal polyps are stratified into non-neoplastic and neoplastic categories. Non-neoplastic lesions predominantly comprise hyperplastic polyps, most commonly situated in the distal rectosigmoid and harboring negligible malignant potential. Conversely, neoplastic premalignant lesions are designated as adenomas: tubular (comprising ~75% of adenomas), tubulovillous, and villous adenomas, the latter carrying up to a 40% risk of malignant transformation when exceeding 2 cm in diameter. Additionally, sessile serrated lesions (SSLs) represent an alternative pathway characterized by BRAF mutations and microsatellite instability (MSI), necessitating rigorous surveillance.

The overwhelming majority of small colorectal polyps remain entirely asymptomatic, detected exclusively via screening protocols. As lesions expand beyond 10–20 mm, clinical signs may emerge: hematochezia (visible bright red blood), positive fecal occult blood tests (FOBT/FIT), unexplained microcytic iron deficiency anemia with chronic fatigue, alteration in bowel habits (alternating diarrhea and constipation), mucous discharge in stool, and vague colicky abdominal cramping. Any rectal bleeding in individuals over 40 years of age constitutes an urgent indication for endoscopic visualization to exclude early malignancy.

Full optical colonoscopy represents the undisputed gold standard for colorectal cancer prevention and screening. Colonoscopy affords high-definition visualization of the mucosal surface up to the cecum, enabling simultaneous polypectomy using cold snares or diathermic electrosurgical loops. Resected specimens undergo mandatory histopathological evaluation to assess margins and dysplasia grading. Based on clinical findings, personalized surveillance intervals are established: typically 3, 5, or 10 years, governed by polyp quantity, histology, and architectural features.

Medical literature strictly refutes misconceptions claiming that established polyps can be eradicated or 'dissolved' through botanical infusions or therapeutic fasting. An established polyp is a discrete neoplastic cellular architecture requiring surgical or endoscopic resection. However, phytotherapeutics and bioactive nutraceuticals (such as curcumin, sulforaphane from broccoli sprouts, resveratrol, and green tea catechins) exhibit legitimate chemopreventive utility post-polypectomy by downregulating cyclooxygenase-2 (COX-2) expression, dampening inflammatory cascades, and reducing the recurrence rate of de novo adenomas.

Primary prevention of adenomatous polyps requires targeted lifestyle and dietary adjustments: 1. High intake of dietary fiber (>30–35 g/day, emphasizing soluble fibers and resistant starch), which accelerates fecal transit, dilutes luminal toxins, and fosters production of short-chain fatty acids (butyrate fuels colonocyte integrity); 2. Strict restriction of red and ultra-processed meats containing mutagenic heterocyclic amines, polycyclic hydrocarbons, and N-nitroso compounds; 3. Adequate calcium (1000–1200 mg/day) and vitamin D3 status to promote cell differentiation; 4. Cessation of tobacco and reduction of alcohol; 5. Regular physical activity, which independently reduces colonic polyp incidence by roughly 25%.